How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XC

NASDAQ:XCUR
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XC

Exicure IncNASDAQ XCUR Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is XCUR undervalued compared to its fair value?

The fair value of XCUR stock is hidden USD. Relative to the market price of 0.535 USD Exicure Inc is hidden.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 29...[More about valuation]

Exicure Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.003 $B

Price:

0.535 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.096

FINANCIALS

Exicure financial for reporting period

Income Statement

0.0005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0008 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0008 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0005 B 100%
-0.0008 B -167%
-0.0008 B -166%

Balance Sheet

0.011 B
0.0022 B

Financial Position Analysis

Assets

0.011 B
Current Assets
0.0015 B
Total non-current assets
0.0092 B

Total current liabilities
0.0027 B
Total non-current liabilities
0.0058 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0004 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Exicure fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-274 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-100 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-101 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is XCUR attractive for investment based on fundamental analysis?

XCUR stock rating is hidden. Exicure is a hidden by Eyestock methodology.

Get XCUR Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-2 666

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

1.169

Debt / Equity ratio:

ROE:

-274

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

XCUR analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for XCUR to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Exicure Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Exicure Inc dividends

XCUR dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About XCUR stock

About the company Exicure Inc

Market cap $B

0.003

Dividend yield

Shares outstanding

4.96463 B

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 29 full-time employees. The company went IPO on 2018-05-09. The company is developing nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. The company is engaged in the development of its preclinical program targeting SCN9A for neuropathic pain; to develop SNA-based treatments in neuroscience targeting Huntingtons disease and Angelman syndrome; to develop Spherical Nucleic Acid (SNA)-based treatments for hair loss disorders; as well as the continued research and development of other therapeutic product candidates. SCN9A is its lead program candidate for the treatment of chronic pain. Cavrotolimod (AST-008) is a toll-like receptor 9 (TLR9), agonist designed for immuno-oncology applications utilizing its SNA technology. Its therapeutic discovery and development efforts are supported by its SNA technology. SNAs are nanoscale constructs consisting of densely packed synthetic nucleic acid molecules that are radially arranged in three dimensions.

XCUR profile

  • Ticker

    XCUR

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    09 May 2018

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    29

  • City

    Chicago

  • Address

    2430 N. Halsted St.

  • Cusip

    30205M200